ReachRxResearch
Home
Research
Sign Up
2026 AHA/ACC/ACS/ASNC/HRS/SCA/SCCT/SCMR/SVM Guideline for Perioperative Cardiovascular Management for Noncardiac Surgery
Back to Research Hub
  1. Home
  2. Research Hub
  3. 2026 AHA/ACC/ACS/ASNC/HRS/SCA/SCCT/SCMR/…

2026 AHA/ACC/ACS/ASNC/HRS/SCA/SCCT/SCMR/SVM Guideline for Perioperative Cardiovascular Management for Noncardiac Surgery

JACC·September 28
Cardiac & Cardiovascular SystemsPractice changingCardiovascular DiseasePerioperative Cardiovascular RiskClinical Practice GuidelineAdult

Summary

View source

What was studied

This AHA/ACC multi-society guideline evaluates perioperative cardiovascular management for adult patients undergoing noncardiac surgery, updating the 2014 ACC/AHA guideline with evidence from a comprehensive literature search (August 2022–March 2023) across MEDLINE, EMBASE, Cochrane Library, and other databases.

Key findings

The guideline supersedes the 2014 ACC/AHA perioperative guideline and provides updated recommendations covering preoperative cardiovascular evaluation, pharmacological therapies, perioperative monitoring, and device management for cardiovascular disease and associated conditions in noncardiac surgery patients.

Study limitations

Literature search was conducted from August 2022 to March 2023 only, meaning studies published after March 2023 are not incorporated; as a consensus guideline, individual recommendations carry varying levels of supporting evidence.

Clinical implications

Clinicians managing adults before noncardiac surgery should adopt this 2026 guideline as the current standard, replacing the 2014 ACC/AHA document, particularly regarding updated pharmacological therapies, monitoring strategies, and device use for perioperative cardiovascular risk.

Caveats

  • Recommendations apply specifically to adult patients undergoing noncardiac surgery and may not generalize to pediatric populations or cardiac surgical settings
  • The evidence base is limited to studies published through March 2023; practice may have evolved since that cutoff
  • This is a guideline document rather than a primary clinical trial; recommendations reflect expert consensus and evidence synthesis of varying quality, not a single controlled study

Related Questions

Explore related topics

What are the updated recommendations for beta-blocker use in perioperative cardiovascular management for noncardiac surgery?How should clinicians manage antiplatelet or anticoagulation therapy perioperatively in patients with coronary artery disease undergoing noncardiac surgery?What preoperative cardiac testing is recommended before high-risk noncardiac surgery in patients with known heart failure or valvular disease?

Publication Details

Year
2026
Journal
JACC
Source
View article
Keep scrolling
More content below.
Up Next